third generation glp 1 Understanding the Next-Gen Weight Loss Drug: Retatrutide (GLP-1, GIP, and Glucagon Receptor Agonist) Emerging Frontiers in GLP-1 Therapeutics:
Description
HOME | DIABETES EDUCATION | ZEPBOUND ALLERGIC REACTION: CAN IT TRIGGER INJECTION SITE ISSUES
Dual agonists reduce appetite, making it tempting to skip meals or eat minimally, but inadequate protein accelerates muscle loss
At present however, even fewer patients have coverage for Wegovy or other GLP-1 RAs for weight loss
GLP-1 agents are no longer confined to glycemic management
Jeppesen PB, Gilroy R, Pertkiewicz M, Allard JP, Messing B, OKeefe SJ
